CG Oncology, Inc. (CGON)
NASDAQ · Healthcare
CG Oncology, Inc. Revenue 2023–2025
CG Oncology, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- CG Oncology, Inc. revenue for the quarter ending March 31, 2026 was 1.1 M, a 1982.69% increase year-over-year.
- CG Oncology, Inc. revenue for the twelve months ending March 31, 2026 was 2.8 M, a 304.77% increase year-over-year.
- CG Oncology, Inc. annual revenue for 2025 was 4.0 M, a 254.70% increase from 2024.
- CG Oncology, Inc. annual revenue for 2024 was 1.1 M, a 458.33% increase from 2023.
- CG Oncology, Inc. annual revenue for 2023 was 204000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
CG Oncology, Inc. Revenue — FAQ
CG Oncology, Inc. (CGON) revenue over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is CG Oncology, Inc.'s revenue?
CG Oncology, Inc. (CGON) reported revenue of $4M for fiscal 2025.
Where can I see CGON's revenue history?
The chart and table above show CG Oncology, Inc.'s revenue by year and by quarter, including the growth rate.